Literature DB >> 30549156

Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.

Irene Sintini1, Christopher G Schwarz1, Peter R Martin2, Jonathan Graff-Radford3, Mary M Machulda4, Matthew L Senjem1,5, Robert I Reid5, Anthony J Spychalla1, Daniel A Drubach3, Val J Lowe1, Clifford R Jack1, Keith A Josephs3, Jennifer L Whitwell1.   

Abstract

Alzheimer's disease (AD) can present with atypical clinical forms where the prominent domain of deficit is not memory, that is, atypical AD. Atypical AD patients show cortical atrophy on MRI, hypometabolism on [18 F]fluorodeoxyglucose (FDG) PET, tau uptake on [18 F]AV-1451 PET, and white matter tract degeneration on diffusion tensor imaging (DTI). How these disease processes relate to each other locally and distantly remains unclear. We aimed to examine multimodal neuroimaging relationships in individuals with atypical AD, using univariate and multivariate techniques at region- and voxel-level. Forty atypical AD patients underwent MRI, FDG-PET, tau-PET, beta-amyloid PET, and DTI. Patients were all beta-amyloid positive. Partial Pearson's correlations were performed between tau and FDG standardized uptake value ratios, gray matter MRI-volumes and white matter tract fractional anisotropy. Sparse canonical correlation analysis was applied to identify multivariate relationships between the same quantities. Voxel-level associations across modalities were also assessed. Tau showed strong local negative correlations with FDG metabolism in the occipital and frontal lobes. Tau in frontal and parietal regions was negatively associated with temporoparietal gray matter MRI-volume. Fractional anisotropy in a set of posterior white matter tracts, including the splenium of the corpus callosum, cingulum, and posterior thalamic radiation, was negatively correlated with parietal and occipital tau, atrophy and, predominantly, with hypometabolism. These results support the view that tau is the driving force behind neurodegeneration in atypical AD, and that a breakdown in structural connectivity is related to cortical neurodegeneration, particularly hypometabolism.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  DTI; FDG; MRI; atypical Alzheimer's disease; multimodal imaging; multivariate analysis; tau

Mesh:

Substances:

Year:  2018        PMID: 30549156      PMCID: PMC6615561          DOI: 10.1002/hbm.24473

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  50 in total

1.  Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Pia M Ghosh; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Ann Neurol       Date:  2014-12-17       Impact factor: 10.422

2.  In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.

Authors:  Julian Dronse; Klaus Fliessbach; Gérard N Bischof; Boris von Reutern; Jennifer Faber; Jochen Hammes; Georg Kuhnert; Bernd Neumaier; Oezguer A Onur; Juraj Kukolja; Thilo van Eimeren; Frank Jessen; Gereon R Fink; Thomas Klockgether; Alexander Drzezga
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.

Authors:  Gil D Rabinovici; William J Jagust; Ansgar J Furst; Jennifer M Ogar; Caroline A Racine; Elizabeth C Mormino; James P O'Neil; Rayhan A Lal; Nina F Dronkers; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

Review 4.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  Correction of PET data for partial volume effects in human cerebral cortex by MR imaging.

Authors:  C C Meltzer; J P Leal; H S Mayberg; H N Wagner; J J Frost
Journal:  J Comput Assist Tomogr       Date:  1990 Jul-Aug       Impact factor: 1.826

6.  Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia.

Authors:  Jennifer L Whitwell; Val J Lowe; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Kejal Kantarci; Samantha M Wille; Matthew L Senjem; Matthew C Murphy; Jeffrey L Gunter; Clifford R Jack; Keith A Josephs
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-14       Impact factor: 10.154

Review 7.  Posterior cortical atrophy.

Authors:  Sebastian J Crutch; Manja Lehmann; Jonathan M Schott; Gil D Rabinovici; Martin N Rossor; Nick C Fox
Journal:  Lancet Neurol       Date:  2012-02       Impact factor: 44.182

8.  FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.

Authors:  Ajay Madhavan; Jennifer L Whitwell; Stephen D Weigand; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Nirubol Tosakulwong; Matthew L Senjem; Jeffrey L Gunter; Val J Lowe; Ronald C Petersen; Clifford R Jack; Keith A Josephs
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

9.  Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease.

Authors:  Gérard N Bischof; Frank Jessen; Klaus Fliessbach; Julian Dronse; Jochen Hammes; Bernd Neumaier; Oezguer Onur; Gereon R Fink; Juraj Kukolja; Alexander Drzezga; Thilo van Eimeren
Journal:  Ann Clin Transl Neurol       Date:  2016-10-20       Impact factor: 4.511

10.  VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis.

Authors:  Sulantha Mathotaarachchi; Seqian Wang; Monica Shin; Tharick A Pascoal; Andrea L Benedet; Min Su Kang; Thomas Beaudry; Vladimir S Fonov; Serge Gauthier; Aurélie Labbe; Pedro Rosa-Neto
Journal:  Front Neuroinform       Date:  2016-06-15       Impact factor: 4.081

View more
  21 in total

1.  Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.

Authors:  Irene Sintini; Jonathan Graff-Radford; Matthew L Senjem; Christopher G Schwarz; Mary M Machulda; Peter R Martin; David T Jones; Bradley F Boeve; David S Knopman; Kejal Kantarci; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

2.  Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.

Authors:  Irene Sintini; Christopher G Schwarz; Peter R Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Robert I Reid; Anthony J Spychalla; Daniel A Drubach; Val J Lowe; Clifford R Jack; Keith A Josephs; Jennifer L Whitwell
Journal:  Hum Brain Mapp       Date:  2018-12-13       Impact factor: 5.038

3.  Diffusion Tensor Imaging Profiles Can Distinguish Diffusivity and Neural Properties of White Matter Injury in Hydrocephalus vs. Non-hydrocephalus Using a Strategy of a Periodic Table of DTI Elements.

Authors:  Nicole C Keong; Christine Lock; Shereen Soon; Aditya Tri Hernowo; Zofia Czosnyka; Marek Czosnyka; John D Pickard; Vairavan Narayanan
Journal:  Front Neurol       Date:  2022-07-06       Impact factor: 4.086

4.  Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech.

Authors:  Rene L Utianski; Peter R Martin; Hugo Botha; Christopher G Schwarz; Joseph R Duffy; Ronald C Petersen; David S Knopman; Heather M Clark; Alissa M Butts; Mary M Machulda; Clifford R Jack; Val J Lowe; Jennifer L Whitwell; Keith A Josephs
Journal:  Cortex       Date:  2019-11-19       Impact factor: 4.027

5.  Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.

Authors:  Kennedy A Josephs; Nha Trang Thu Pham; Jonathan Graff-Radford; Mary M Machulda; Val J Lowe; Jennifer L Whitwell
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

Review 6.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Authors:  Stephen C Cunnane; Mark J Millan; Eugenia Trushina; Cecilie Morland; Alessandro Prigione; Gemma Casadesus; Zane B Andrews; M Flint Beal; Linda H Bergersen; Roberta D Brinton; Suzanne de la Monte; Anne Eckert; Jenni Harvey; Ross Jeggo; Jack H Jhamandas; Oliver Kann; Clothide Mannoury la Cour; William F Martin; Gilles Mithieux; Paula I Moreira; Michael P Murphy; Klaus-Armin Nave; Tal Nuriel; Stéphane H R Oliet; Frédéric Saudou; Mark P Mattson; Russell H Swerdlow
Journal:  Nat Rev Drug Discov       Date:  2020-07-24       Impact factor: 84.694

7.  A technical review of canonical correlation analysis for neuroscience applications.

Authors:  Xiaowei Zhuang; Zhengshi Yang; Dietmar Cordes
Journal:  Hum Brain Mapp       Date:  2020-06-27       Impact factor: 5.038

8.  Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer's Disease.

Authors:  Irene Sintini; Jonathan Graff-Radford; David T Jones; Hugo Botha; Peter R Martin; Mary M Machulda; Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Cereb Cortex       Date:  2021-02-05       Impact factor: 5.357

9.  Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum.

Authors:  Leonardo Iaccarino; Renaud La Joie; Lauren Edwards; Amelia Strom; Daniel R Schonhaut; Rik Ossenkoppele; Julie Pham; Taylor Mellinger; Mustafa Janabi; Suzanne L Baker; David Soleimani-Meigooni; Howard J Rosen; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Cereb Cortex       Date:  2021-01-01       Impact factor: 5.357

10.  Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.

Authors:  Amelia Strom; Leonardo Iaccarino; Lauren Edwards; Orit H Lesman-Segev; David N Soleimani-Meigooni; Julie Pham; Suzanne L Baker; Susan M Landau; William J Jagust; Bruce L Miller; Howard J Rosen; Maria Luisa Gorno-Tempini; Gil D Rabinovici; Renaud La Joie
Journal:  Brain       Date:  2022-04-18       Impact factor: 15.255

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.